Protiva Biotherapeutics Inc.

Part of Arbutus Biopharma Corporation

UEI
R9VYBEQJ57R8
CAGE
L4893
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
arbutusbio.com
Founded
2007
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Stable nucleic acid lipid particle (SNALP)-enabled sirna-based therapy for hemorrhagic fever W81XWH0720016 Department of the Army $1,611,758

Quick answers

Is Protiva Biotherapeutics Inc. registered in SAM.gov?

Protiva Biotherapeutics Inc.'s SAM.gov registration expired on May 10, 2019.

What is Protiva Biotherapeutics Inc.'s CAGE code?

Protiva Biotherapeutics Inc.'s CAGE code is L4893, and its Unique Entity ID (UEI) is R9VYBEQJ57R8.

What is Protiva Biotherapeutics Inc.'s most recent federal award?

Protiva Biotherapeutics Inc.'s most recent federal grant award is Stable nucleic acid lipid particle (SNALP)-enabled sirna-based therapy for hemorrhagic fever (W81XWH0720016), from Department of the Army, on January 1, 2007.

On GovTribe

See Protiva Biotherapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe